The ELF™ Test is a simple, effective blood test with proven patient outcomes data to assess prognosis in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH), a type of non-alcoholic fatty liver disease (NAFLD) characterized by inflammation of the liver. Clinicians can utilize the ELF score to understand the likelihood of progression to cirrhosis and other liver-related clinical events.
Reminder: At this time, patients are required to have a prescription from their healthcare professional in order to receive an ELF Test.
